BTIG reaffirms Buy on Adaptive Biotechnologies; $34 target
BTIG maintained a Buy rating on Adaptive Biotechnologies with a $34.00 price target, implying 22.0% upside versus the Sep 21 close of $27.86.
Story updates
10:19:44 AM UTC
SquawkNews
Ratings actions GMT) Adaptive Biotechnologies Is Maintained at Buy by BTIGRatings actions